Medical Services

Severe obesity, medically termed Class III obesity, is defined as having a body mass index (BMI) of 40 or higher—nearly twice the threshold for overweight status. This chronic, systemic condition involves excessive body fat accumulation that impairs organ and tissue function, significantly elevating health risks.

Individuals with severe obesity face substantially higher chances of developing type 2 diabetes, cardiovascular disease, hypertension, obstructive sleep apnea, certain cancers, and mobility limitations. The condition arises from complex interactions among genetics, environment, metabolism, and behavioral factors, and it is not simply a result of poor willpower.

Treatment requires a comprehensive, personalized approach. First-line strategies include structured healthy eating plans, regular physical activity tailored to individual capacity, and behavior modification programs. For many patients, FDA-approved weight-loss medications (such as GLP-1 agonists) provide meaningful results; emerging drugs like retatrutide have shown up to 30% body-weight reduction in clinical trials. Bariatric surgery remains the most effective long-term intervention for eligible candidates, producing sustained weight loss and improving obesity-related comorbidities.

Recognizing severe obesity as a treatable medical disease—not a cosmetic issue—is essential for reducing stigma and improving patient outcomes. Early intervention and ongoing support from healthcare professionals are critical for successful management.